BR0113048A - Lêvedo modificados e utilizações, principalmente para a produção de derivados esteroidianos - Google Patents

Lêvedo modificados e utilizações, principalmente para a produção de derivados esteroidianos

Info

Publication number
BR0113048A
BR0113048A BR0113048-0A BR0113048A BR0113048A BR 0113048 A BR0113048 A BR 0113048A BR 0113048 A BR0113048 A BR 0113048A BR 0113048 A BR0113048 A BR 0113048A
Authority
BR
Brazil
Prior art keywords
production
strains
steroid derivatives
mainly
steroid
Prior art date
Application number
BR0113048-0A
Other languages
English (en)
Other versions
BRPI0113048B1 (pt
BRPI0113048B8 (pt
Original Assignee
Aventis Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma filed Critical Aventis Pharma
Publication of BR0113048A publication Critical patent/BR0113048A/pt
Publication of BRPI0113048B1 publication Critical patent/BRPI0113048B1/pt
Publication of BRPI0113048B8 publication Critical patent/BRPI0113048B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0083Miscellaneous (1.14.99)
    • C12N9/0087Steroid 21-monooxygenase (1.14.99.10)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • C12P33/06Hydroxylating

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)

Abstract

"LêVEDOS MODIFICADOS E UTILIZAçõES, PRINCIPALMENTE PARA A PRODUçãO DE DERIVADOS ESTEROIDIANOS". A presente invenção refere-se a novas cepas de lêvedo, processos e construções genéticas para seu preparo, assim como sua utilização para a síntese ou a modificação de compostos esteroidianos. Mais particularmente, a invenção descreve cepas que apresentam uma atividade de tipo 20<244>-HSD diminuída, notadamente por modificação dos genes GCY1 e/ou YPR1. As cepas de lêvedo da invenção permitem melhorar a eficácia da síntese ou aumentar a seletividade ou os rendimentos do processo, assim como a qualidade do produto final. As cepas, processos e compostos da invenção são úteis na pesquisa, no desenvolvimento e na produção de produtos com atividade terapêutica ou profilática, no homem ou no animal, notadamente de derivados esteroidianos.
BRPI0113048A 2000-08-08 2001-07-24 cepas saccharomyces cerevisiae com genes ypr1 e gcy1 modificados e tendo atividade 20 alfa-hidroxiesteróide dehidrogenase (20 alfa-hsd) reduzida, seus usos na preparação de compostos esteroidais, bem como processos de modificação de hidroxiprogesterona e 11-deoxicortisol BRPI0113048B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0010437A FR2812884B1 (fr) 2000-08-08 2000-08-08 Levures modifiees et utilisations, notamment pour la production de derives steroidiens
PCT/FR2001/002417 WO2002012536A1 (fr) 2000-08-08 2001-07-24 Levures modifiees et utilisations, notamment pour la production de derives steroidiens

Publications (3)

Publication Number Publication Date
BR0113048A true BR0113048A (pt) 2003-07-01
BRPI0113048B1 BRPI0113048B1 (pt) 2015-12-22
BRPI0113048B8 BRPI0113048B8 (pt) 2021-05-25

Family

ID=8853403

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0113048A BRPI0113048B8 (pt) 2000-08-08 2001-07-24 cepas saccharomyces cerevisiae com genes ypr1 e gcy1 modificados e tendo atividade 20 alfa-hidroxiesteróide dehidrogenase (20 alfa-hsd) reduzida, seus usos na preparação de compostos esteroidais, bem como processos de modificação de hidroxiprogesterona e 11-deoxicortisol

Country Status (22)

Country Link
US (2) US7879592B2 (pt)
EP (1) EP1313873B1 (pt)
JP (1) JP4864277B2 (pt)
KR (1) KR100860702B1 (pt)
AR (1) AR030080A1 (pt)
AT (1) ATE390479T1 (pt)
AU (2) AU2001278562B2 (pt)
BR (1) BRPI0113048B8 (pt)
CA (1) CA2418370C (pt)
CY (1) CY1108080T1 (pt)
DE (1) DE60133396T2 (pt)
DK (1) DK1313873T3 (pt)
ES (1) ES2300347T3 (pt)
FR (1) FR2812884B1 (pt)
IL (2) IL154294A0 (pt)
MX (1) MXPA03000702A (pt)
NO (1) NO334484B1 (pt)
NZ (1) NZ523612A (pt)
PT (1) PT1313873E (pt)
TW (1) TWI315739B (pt)
WO (1) WO2002012536A1 (pt)
ZA (1) ZA200300376B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2812884B1 (fr) 2000-08-08 2002-11-08 Aventis Pharma Sa Levures modifiees et utilisations, notamment pour la production de derives steroidiens
FR2820145B1 (fr) 2001-01-31 2004-01-23 Aventis Pharma Sa Souche de levure produisant des steroides de facon autonome
FR2976949B1 (fr) * 2011-06-21 2015-08-28 Sanofi Sa Procede de preparation de levures genetiquement transformees capables de produire une molecule d'interet a haut titre

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5571250A (en) 1978-11-22 1980-05-29 Hatano Kk Paper for paper box with lid and method of assembling paper box with lid by using same
BE889407A (fr) 1980-06-27 1981-10-16 Mallinckrodt Inc Amelioration du procede de preparation d'un lysat de limule
JPS62181571A (ja) 1986-08-11 1987-08-08 Canon Inc 画像処理装置
JPS63181571A (ja) 1987-01-22 1988-07-26 Matsushita Electric Ind Co Ltd 自動焦点整合装置
JPS6447380A (en) 1987-08-19 1989-02-21 Agency Ind Science Techn Steroid-oxidizing yeast strain
JPS6471250A (en) 1987-09-11 1989-03-16 Nec Corp Multi-function telephone set
EP0340878B1 (en) 1988-05-06 2001-05-16 Aventis Pharma S.A. Process for the biochemical oxidation of steroids and genetically engineered cells to be used therefor
JPH0231680A (ja) * 1988-07-22 1990-02-01 Agency Of Ind Science & Technol チトクロムP450c↓2↓1産生酵母菌株
CN1042567A (zh) 1988-09-23 1990-05-30 吉斯特-布罗卡迪斯公司 类固醇多步氧化方法和所用的遗传工程细胞
JPH02249488A (ja) * 1989-03-22 1990-10-05 Sumitomo Chem Co Ltd チトクロムP450↓c↓2↓1と酵母NADPH‐チトクロムP450還元酵素の融合酸化酵素、該酵素をコードする遺伝子および該酵素の製造方法
JP2645130B2 (ja) 1989-03-31 1997-08-25 日清製粉株式会社 ステロイド誘導体
FR2678611B1 (fr) 1991-07-04 1995-01-20 Roussel Uclaf Nouveaux esters pyrethrinouides de l'alcool 1,3,4,5,6,7-hexahydro 1,3-dioxo-2h-isoindol-2-yl-methylique, leur procede de preparation et leur application comme pesticides.
JP3363197B2 (ja) 1992-06-18 2003-01-08 麒麟麦酒株式会社 アルコールアセチルトランスフェラーゼ遺伝子およびその利用
US5547868A (en) 1993-06-09 1996-08-20 Regents Of The University Of California Cholesterol disposal fusion enzymes
IL116872A (en) 1995-02-15 2004-12-15 Aventis Pharma Sa Delta 5,7-Strol Reductase from Arbidopsis Thaliana
JP4093598B2 (ja) 1995-03-14 2008-06-04 大関株式会社 新規なアルコールアセチルトランスフェラーゼ遺伝子
DE19744212B4 (de) 1997-09-30 2006-01-19 Schering Ag Verfahren zur Herstellung von Ergosterol und dessen Zwischenprodukten mittels rekombinanter Hefen
US6303302B1 (en) * 1997-11-19 2001-10-16 The Whitehead Institute For Biomedical Research Regulation of fungal gene expression
FR2774393B1 (fr) 1998-02-05 2000-03-24 Hoechst Marion Roussel Inc Souches de levure ayant le gene atf2 interrompu et leurs applications
FR2799206A1 (fr) 1999-10-05 2001-04-06 Transgene Sa Procede de production de steroides modifies par fermentation de levures
FR2812884B1 (fr) 2000-08-08 2002-11-08 Aventis Pharma Sa Levures modifiees et utilisations, notamment pour la production de derives steroidiens
FR2820145B1 (fr) 2001-01-31 2004-01-23 Aventis Pharma Sa Souche de levure produisant des steroides de facon autonome

Also Published As

Publication number Publication date
TWI315739B (en) 2009-10-11
BRPI0113048B1 (pt) 2015-12-22
AU2001278562B2 (en) 2006-07-20
US20110104749A1 (en) 2011-05-05
FR2812884B1 (fr) 2002-11-08
BRPI0113048B8 (pt) 2021-05-25
IL154294A0 (en) 2003-09-17
CA2418370C (fr) 2014-03-11
DE60133396D1 (de) 2008-05-08
KR100860702B1 (ko) 2008-09-26
PT1313873E (pt) 2008-05-27
ES2300347T3 (es) 2008-06-16
JP2004505634A (ja) 2004-02-26
IL154294A (en) 2010-05-31
NO334484B1 (no) 2014-03-17
KR20030024842A (ko) 2003-03-26
FR2812884A1 (fr) 2002-02-15
NO20030606D0 (no) 2003-02-07
CA2418370A1 (fr) 2002-02-14
MXPA03000702A (es) 2003-06-04
US20040082025A1 (en) 2004-04-29
NO20030606L (no) 2003-02-07
EP1313873B1 (fr) 2008-03-26
AR030080A1 (es) 2003-08-13
EP1313873A1 (fr) 2003-05-28
US8173402B2 (en) 2012-05-08
NZ523612A (en) 2004-11-26
WO2002012536A1 (fr) 2002-02-14
US7879592B2 (en) 2011-02-01
ATE390479T1 (de) 2008-04-15
DK1313873T3 (da) 2008-07-14
ZA200300376B (en) 2004-01-22
JP4864277B2 (ja) 2012-02-01
DE60133396T2 (de) 2009-07-09
AU7856201A (en) 2002-02-18
CY1108080T1 (el) 2014-02-12

Similar Documents

Publication Publication Date Title
JP6022603B2 (ja) 皮膚美白用化粧料組成物、予防または治療用薬剤学的組成物、及び治療用薬剤学的組成物
BR0010806A (pt) Métodos e materiais para a sìntese de produtos orgânicos
BR0209483A (pt) Genes tyra e seus usos
BRPI0415619A (pt) método para intensificar a fermentação de substratos de carboidratos e aumentar o rendimento de álcoois
BR0307294A (pt) ésteres de ácido fluorenocarboxìlico, processo para sua preparação bem como seu uso como medicamento
CY1108279T1 (el) 17α-ΑΛΚΥΛΟ-17β-ΟΞΥ-ΟΙΣΤΡΑΤΡΙΕΝΙΑ ΚΑΙ ΕΝΔΙΑΜΕΣΑ ΠΡΟΪΟΝΤΑ ΓΙΑ ΤΗΝ ΠΑΡΑΓΩΓΗ ΑΥΤΩΝ, Η ΧΡΗΣΗ ΤΩΝ 17α-ΑΛΚΥΛΟ-17β-ΟΞΥ-ΟΙΣΤΡΑΤΡΙΕΝΙΩΝ ΓΙΑ ΤΗΝ ΠΑΡΑΓΩΓΗ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΜΕΣΩΝ ΚΑΘΩΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΑ ΠΑΡΑΣΚΕΥΑΣΜΑΤΑ
BRPI0511072B8 (pt) compostos derivados de alquinila como moduladores dos receptores de glutamato metabotróbico, seus usos e suas composições farmacêuticas
BRPI0408347A (pt) derivados de pirimidina
BRPI0518601A2 (pt) processo para preparaÇço de derivados de piperazin-2-ona anelados bem como produtos intermediÁrios do processo
BRPI0415683A (pt) inibidores da reabsorção de norepinefrina para o tratamento de distúrbios do sistema nervoso central
BRPI0507604A (pt) medicamentos com atividade de receptor hm74a
SG151330A1 (en) Process for production of optically active amine derivatives
BR0204588A (pt) Derivados de n-alquil-adamantil-triazinil-benzamida
AU2003263552A1 (en) Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
BR0007980A (pt) Processo para a preparação de derivadosmulti-reticulados de ácido hialurÈnico, hamulti-reticulado, ha reticulado em si próprio,produto, e, uso de ha
BR0314611A (pt) Compostos de tiazol para o tratamento de distúrbios neurodegenerativos
BRPI0609703B8 (pt) compostos de éster de ácido benzóico, composições, usos, e métodos relacionados aos mesmos
ATE282033T1 (de) Synthese von beta-lapachone und entsprechender zwischenprodukte
BRPI0407145A (pt) Pirazolilcarboxanilidas para combater microorganismos indesejados
FR2451942A1 (fr) Preparation d&#39;enzymes immobilisees
BR0208534A (pt) Processo para preparação de 4,6-diaminopirimido[5,4-d]pirimidinas
Karaman Design of prodrugs to replace commonly used drugs having bitter sensation
NZ515891A (en) New vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
BRPI0415454A (pt) 1,3-dimetilbutilcarboxanilidas para controle de microorganismos indesejáveis
BR0113048A (pt) Lêvedo modificados e utilizações, principalmente para a produção de derivados esteroidianos

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C12P 33/06 , C12N 15/53 , C12N 1/16

Ipc: C12P 33/06 (2006.01), C12N 15/53 (2006.01), C12N 1

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 22/12/2015, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/07/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 24/07/2021